Lucintel’s latest market report analyzed that genotyping provides attractive opportunities in diagnostics, drug discovery personalized medicine, academic research, and agriculture applications. The genotyping market is expected to grow at a CAGR of 20%-25%. In this market, reagents and kits are the largest segment by product, whereas personalized medicine are largest by application.
Download Brochure of this report by clicking on https://www.lucintel.com/genotyping-market.aspx
Based on product, the genotyping market is segmented into reagents and kits, instruments, and services. The reagents and kits segment accounted for the largest share of the market in 2020 due to a wide usage rate, surging demand for genotyping tests, cost-effectiveness, and easy availability of reagents.
Browse in-depth TOC on “Genotyping Market”
XX – Tables
XX – Figures
The genotyping market is marked by the presence of several big and small players. Some of the prominent players offering Genotyping include QIAGEN, Affymetrix, Illumina, Thermo Fisher Scientific, General Electric, Agilent Technologies, and Roche.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link firstname.lastname@example.org.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.